187 related articles for article (PubMed ID: 7853549)
1. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
[TBL] [Abstract][Full Text] [Related]
2. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
[TBL] [Abstract][Full Text] [Related]
4. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
[TBL] [Abstract][Full Text] [Related]
5. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
6. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
Epstein JI; Carmichael M; Partin AW; Walsh PC
J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
[TBL] [Abstract][Full Text] [Related]
7. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
Epstein JI; Pizov G; Steinberg GD; Carter HB; Pitcock R; Armas OA; Partin A; Walsh PC
J Urol; 1992 Jul; 148(1):87-91. PubMed ID: 1613888
[TBL] [Abstract][Full Text] [Related]
8. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
Lee SE; Currin SM; Paulson DF; Walther PJ
J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
[TBL] [Abstract][Full Text] [Related]
11. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
[TBL] [Abstract][Full Text] [Related]
12. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy.
Di Silverio F; D'Eramo G; Buscarini M; Sciarra A; Casale P; Di Nicola S; Loreto A; Seccareccia F; De Vita R
Eur Urol; 1996; 30(3):316-21. PubMed ID: 8931963
[TBL] [Abstract][Full Text] [Related]
14. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
15. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
Robertson CN; Paulson DF
Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
[TBL] [Abstract][Full Text] [Related]
16. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?
Brinker DA; Ross JS; Tran TA; Jones DM; Epstein JI
J Urol; 1999 Dec; 162(6):2036-9. PubMed ID: 10569563
[TBL] [Abstract][Full Text] [Related]
17. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC
J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Epstein JI; Pizov G; Walsh PC
Cancer; 1993 Jun; 71(11):3582-93. PubMed ID: 7683970
[TBL] [Abstract][Full Text] [Related]
19. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.
Lerner SE; Blute ML; Bergstralh EJ; Bostwick DG; Eickholt JT; Zincke H
J Urol; 1996 Jul; 156(1):137-43. PubMed ID: 8648775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]